A daily dollop.

That may be all the tamoxifen women need to prevent local breast cancer recurrences. Early data shows promising results with breast pharmacokinetics using a topical tamoxifen gel as primary and secondary prevention for women with high baseline risk or history of DCIS. | NCI 2018